1. The Computerized Cognitive Composite (C3) in A4, an Alzheimer’s Disease Secondary Prevention Trial
- Author
-
Papp, Kathryn V, Rentz, DM, Maruff, P, Sun, C-K, Raman, R, Donohue, MC, Schembri, A, Stark, C, Yassa, MA, Wessels, AM, Yaari, R, Holdridge, KC, Aisen, PS, and Sperling, RA
- Subjects
Psychology ,Applied and Developmental Psychology ,Clinical Trials and Supportive Activities ,Clinical Research ,Alzheimer's Disease ,Behavioral and Social Science ,Acquired Cognitive Impairment ,Neurosciences ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Brain Disorders ,Neurodegenerative ,Prevention ,Dementia ,Aging ,Aged ,Alzheimer Disease ,Amyloid beta-Peptides ,Biomarkers ,Clinical Trials as Topic ,Computers ,Cross-Sectional Studies ,Feasibility Studies ,Female ,Humans ,Male ,Mental Status and Dementia Tests ,Qualitative Research ,Secondary Prevention ,Digital biomarkers ,cognition ,computerized testing ,preclinical Alzheimer's disease ,secondary prevention ,preclinical Alzheimer’s disease ,Biological psychology ,Cognitive and computational psychology - Abstract
BackgroundComputerized cognitive assessments may improve Alzheimer's disease (AD) secondary prevention trial efficiency and accuracy. However, they require validation against standard outcomes and relevant biomarkers.ObjectiveTo assess the feasibility and validity of the tablet-based Computerized Cognitive Composite (C3).DesignCross-sectional analysis of cognitive screening data from the A4 study (Anti-Amyloid in Asymptomatic AD).SettingMulti-center international study.ParticipantsClinically normal (CN) older adults (65-85; n=4486).MeasurementsParticipants underwent florbetapir-Positron Emission Tomography for Aβ+/- classification. They completed the C3 and standard paper and pencil measures included in the Preclinical Alzheimer's Cognitive Composite (PACC). The C3 combines memory measures sensitive to change over time (Cogstate Brief Battery-One Card Learning) and measures shown to be declining early in AD including pattern separation (Behavioral Pattern Separation Test- Object- Lure Discrimination Index) and associative memory (Face Name Associative Memory Exam- Face-Name Matching). C3 acceptability and completion rates were assessed using qualitative and quantitative methods. C3 performance was explored in relation to Aβ+/- groups (n=1323/3163) and PACC.ResultsC3 was feasible for CN older adults to complete. Rates of incomplete or invalid administrations were extremely low, even in the bottom quartile of cognitive performers (PACC). C3 was moderately correlated with PACC (r=0.39). Aβ+ performed worse on C3 compared with Aβ- [unadjusted Cohen's d=-0.22 (95%CI: -0.31,-0.13) p
- Published
- 2021